Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience.
acute myeloid leukemia
elderly
minimal residual disease
molecular markers
prognosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Apr 2019
22 Apr 2019
Historique:
received:
24
02
2019
revised:
23
03
2019
accepted:
08
04
2019
entrez:
25
4
2019
pubmed:
25
4
2019
medline:
25
4
2019
Statut:
epublish
Résumé
Although the outcome in younger adults with acute myeloid leukemia (AML) has improved, the benefit associated with standard intensive chemotherapy in older patients remains debatable. In this study, we investigated the incidence and the prognostic significance of genetic characteristics according to treatment intensity in patients aged 60 years or older. On the 495 patients of our cohort,
Identifiants
pubmed: 31013658
pii: cancers11040570
doi: 10.3390/cancers11040570
pmc: PMC6520979
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Blood. 2001 Jan 1;97(1):89-94
pubmed: 11133746
Nat Genet. 2001 Mar;27(3):263-70
pubmed: 11242107
Blood. 2002 Oct 15;100(8):2717-23
pubmed: 12351377
Leukemia. 2002 Oct;16(10):2115-21
pubmed: 12357365
Blood. 2003 Feb 1;101(3):837-45
pubmed: 12393383
Blood. 2003 Sep 15;102(6):2198-204
pubmed: 12791658
Haematologica. 2004 Sep;89(9):1082-90
pubmed: 15377469
Blood. 2005 Aug 15;106(4):1479-87
pubmed: 15827136
Cancer. 2006 Mar 1;106(5):1090-8
pubmed: 16435386
Blood. 2006 May 1;107(9):3481-5
pubmed: 16455952
Stem Cells. 2006 May;24(5):1143-9
pubmed: 16456126
Leuk Lymphoma. 2006 Oct;47(10):2062-9
pubmed: 17071477
Blood. 2009 Apr 30;113(18):4179-87
pubmed: 19008455
Cancer. 2009 Jun 1;115(11):2472-81
pubmed: 19322894
J Clin Oncol. 2009 Nov 20;27(33):5580-6
pubmed: 19858393
Blood. 2010 Jan 21;115(3):453-74
pubmed: 19880497
Blood. 2010 Mar 4;115(9):1690-6
pubmed: 20018913
J Clin Oncol. 2010 Aug 10;28(23):3717-23
pubmed: 20625116
Blood. 2010 Nov 25;116(22):4422-9
pubmed: 20668231
Br J Haematol. 2011 Feb;152(4):493-6
pubmed: 20955413
J Clin Oncol. 2011 Jul 1;29(19):2709-16
pubmed: 21555683
Blood. 2011 Jul 14;118(2):409-12
pubmed: 21596855
N Engl J Med. 2012 Mar 22;366(12):1090-8
pubmed: 22417201
J Clin Oncol. 2012 Dec 20;30(36):4515-23
pubmed: 22987078
PLoS One. 2012;7(12):e51527
pubmed: 23251566
Leuk Res Treatment. 2013;2013:756703
pubmed: 23691328
Blood Cancer J. 2014 Feb 28;4:e188
pubmed: 24583534
PLoS One. 2014 Mar 07;9(3):e89560
pubmed: 24608088
J Clin Oncol. 1989 Sep;7(9):1268-74
pubmed: 2475589
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Clin Lymphoma Myeloma Leuk. 2015 Aug;15(8):477-83
pubmed: 25843415
Ann Hematol. 2015 Aug;94(8):1319-26
pubmed: 25869029
Leuk Res. 2015 Dec;39(12):1443-7
pubmed: 26467814
Leuk Lymphoma. 2017 Jan;58(1):110-117
pubmed: 27184036
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
J Clin Oncol. 2017 Jan 10;35(2):185-193
pubmed: 28056203
Leukemia. 2017 Jul;31(7):1640-1644
pubmed: 28366934
Cell Stem Cell. 2017 Sep 7;21(3):374-382.e4
pubmed: 28803919
Leukemia. 2018 Jan;32(1):241-244
pubmed: 28919634
Ann Hematol. 2017 Dec;96(12):1993-2003
pubmed: 29090343
Blood Adv. 2017 Aug 17;1(19):1546-1550
pubmed: 29296796
Haematologica. 2018 Nov;103(11):1853-1861
pubmed: 29903761
J Clin Oncol. 2018 Sep 10;36(26):2684-2692
pubmed: 30024784
Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):e545-e550
pubmed: 30082225
Blood. 2019 Jan 3;133(1):7-17
pubmed: 30361262
Ann Intern Med. 1985 Oct;103(4):620-5
pubmed: 3862359
Cancer Res. 1996 Mar 15;56(6):1418-25
pubmed: 8640834